Literature DB >> 2171217

Identification of gene 4 alleles among human rotaviruses by polymerase chain reaction-derived probes.

G Larralde1, J Flores.   

Abstract

Four different alleles of the gene encoding VP4, an outer capsid rotavirus protein, have been recognized among human rotaviruses. To investigate the relative frequency of these alleles, hybridization probes corresponding to a hyperdivergent region (nucleotides 205 to 554) of the fourth gene from three human rotavirus strains, Wa, DS1, and M37 (each of which has a distinct gene four allele), were synthesized by the polymerase chain reaction (PCR) method, using as templates either cloned DNA or cDNA. The latter were obtained by reverse transcription of viral RNA from each of the three strains. The probes were hybridized to heat-denatured rotavirus double-stranded RNA (dsRNA) or single-stranded RNA (ssRNA) which was directly dotted onto nylon membranes. Under hybridization conditions of high stringency (50% formamide, 4x SSC, 54 degrees), it was possible to detect this region in as little as 4 ng of total rotavirus RNA. The probes enabled the detection and classification of these three gene 4 alleles in rotavirus strains recovered from field studies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171217     DOI: 10.1016/0042-6822(90)90317-k

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  26 in total

1.  Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995.

Authors:  L E Unicomb; G Podder; J R Gentsch; P A Woods; K Z Hasan; A S Faruque; M J Albert; R I Glass
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  Evidence for two serotype G3 subtypes among equine rotaviruses.

Authors:  G F Browning; R M Chalmers; T A Fitzgerald; D R Snodgrass
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

3.  Development of cDNA probes for typing group A bovine rotaviruses on the basis of VP4 specificity.

Authors:  A V Parwani; B I Rosen; M A McCrae; L J Saif
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

4.  Distribution of serotypes of human rotavirus in different populations.

Authors:  P A Woods; J Gentsch; V Gouvea; L Mata; M Santosham; Z S Bai; S Urasawa; R I Glass
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

5.  Sequence conservation within neutralization epitope regions of VP7 and VP4 proteins of human serotype G4 rotavirus isolates.

Authors:  E A Palombo; R F Bishop; R G Cotton
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

6.  Typing of human rotavirus VP4 by an enzyme immunoassay using monoclonal antibodies.

Authors:  B S Coulson
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

7.  Detection and characterization of novel rotavirus strains in the United States.

Authors:  M Ramachandran; J R Gentsch; U D Parashar; S Jin; P A Woods; J L Holmes; C D Kirkwood; R F Bishop; H B Greenberg; S Urasawa; G Gerna; B S Coulson; K Taniguchi; J S Bresee; R I Glass
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

8.  Antigenic and genomic diversity of human rotavirus VP4 in two consecutive epidemic seasons in Mexico.

Authors:  L Padilla-Noriega; M Méndez-Toss; G Menchaca; J F Contreras; P Romero-Guido; F I Puerto; H Guiscafré; F Mota; I Herrera; R Cedillo; O Muñoz; J Calva; M L Guerrero; B S Coulson; H B Greenberg; S López; C F Arias
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

9.  Comparison of enzyme immunoassay, PCR, and type-specific cDNA probe techniques for identification of group A rotavirus gene 4 types (P types).

Authors:  P J Masendycz; E A Palombo; R J Gorrell; R F Bishop
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

10.  Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites.

Authors:  C D Kirkwood; R F Bishop; B S Coulson
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.